A Randomized, Open Label, Balanced, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Bioequivalence Study of Levocetirizine Dihydrochloride 5 mg Tablets With Xyzal 5 mg Tablets in Normal, Healthy, Adult, Human Subjects Under Fasting Condition

Trial Profile

A Randomized, Open Label, Balanced, Two-Treatment, Two-Period, Two-Sequence, Single Dose, Crossover, Bioequivalence Study of Levocetirizine Dihydrochloride 5 mg Tablets With Xyzal 5 mg Tablets in Normal, Healthy, Adult, Human Subjects Under Fasting Condition

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Nov 2012

At a glance

  • Drugs Levocetirizine (Primary)
  • Indications Allergic rhinitis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 30 Nov 2012 Primary endpoint amended as reported by ClinicalTrials.gov.
    • 22 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top